Correlation Between Immix Biopharma and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Capricor Therapeutics, you can compare the effects of market volatilities on Immix Biopharma and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Capricor Therapeutics.
Diversification Opportunities for Immix Biopharma and Capricor Therapeutics
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Immix and Capricor is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Immix Biopharma and Capricor Therapeutics
Given the investment horizon of 90 days Immix Biopharma is expected to under-perform the Capricor Therapeutics. In addition to that, Immix Biopharma is 1.07 times more volatile than Capricor Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Capricor Therapeutics is currently generating about -0.03 per unit of volatility. If you would invest 1,413 in Capricor Therapeutics on October 22, 2024 and sell it today you would lose (43.00) from holding Capricor Therapeutics or give up 3.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Capricor Therapeutics
Performance |
| Timeline |
| Immix Biopharma |
| Capricor Therapeutics |
Immix Biopharma and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Capricor Therapeutics
The main advantage of trading using opposite Immix Biopharma and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |